18.09.2023 09:00
Last year, Versant Ventures, through its Ridgeline Discovery Engine, spun out two biotech startups successfully. The journey for Its third venture, Vertical bio, which develops of novel cancer therapies, has been short: the company has been acquired by Pierre Fabre Laboratories, a €2.7 billion French medical and beauty care company.